Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Failure To Implement DTC Guidelines Could Trigger DOJ Scrutiny – Asst. U.S. Attorney

This article was originally published in The Pink Sheet Daily

Executive Summary

Inappropriate direct-to-consumer advertising campaigns also expose companies to greater product liability, Assistant U.S. Attorney Meriwether says.

You may also be interested in...

PhRMA DTC Principles Call For End Of Reminder Ads

Independent review panel will be established to handle complaints about pharmaceutical advertising.

Vioxx DTC Ads Do Not Undercut “Learned Intermediary” Defense, Merck Says

“We think our DTC ads are wholly consistent with the philosophy underlying the learned intermediary rule,” General Counsel Frazier says. Merck expects the first Vioxx personal injury trial will commence in the first half of 2005 in either Texas or Alabama.

NDAs Should Include More Cross-Study Analysis, FDA Says In Draft Guidance

FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts